BUZZ-Vir 因肿瘤治疗早期试验的积极数据而跃升

Reuters
08 Jan

((自动化翻译由路透提供,请见免责声明 ))

1月8日 - ** 药物开发商Vir生物技术公司 股价盘前上涨33.2%至10.50美元

** 该公司称其药物VIR-5818和VIR-5500在早期试验中对各种实体瘤患者显示出令人信服的 (link)。

** 称VIR-5818在50%的HER2阳性癌症患者中显示肿瘤缩小

** HER2是一种刺激癌细胞快速生长的蛋白质

** VIR公司称,所有12名服用VIR-5500的患者的前列腺特异性抗原水平都有所下降,而前列腺特异性抗原是前列腺癌的标志。

** 截至上次收盘,股价在过去 12 个月中下跌了 25.6

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10